Cell Source, Inc. Restricted Cash and Cash Equivalents
Cell Source, Inc. (CLCS) had Restricted Cash and Cash Equivalents of $93.09 thousand as of 2021-12-31, per its 10-K filed 2022-04-15.
Discontinued › Balance Sheet › Assets › Restricted Cash and Cash Equivalent
us-gaap:RestrictedCashAndCashEquivalents · last filed 2022-04-15
- 2021-12-31: Restricted Cash and Cash Equivalents $93.09K.
- 2021-09-30: Restricted Cash and Cash Equivalents $599.45K.
- 2021-06-30: Restricted Cash and Cash Equivalents $85.20K.
- 2021-03-31: Restricted Cash and Cash Equivalents $103.09K.
| Period end | Restricted Cash and Cash Equivalents |
|---|---|
| 2021-12-31 | $93.09K 10-K · filed 2022-04-15 |
| 2021-09-30 | $599.45K 10-Q · filed 2021-11-15 |
| 2021-06-30 | $85.20K 10-Q · filed 2021-08-12 |
| 2021-03-31 | $103.09K 10-Q · filed 2021-05-17 |
| 2020-12-31 | $245.12K 10-K · filed 2022-04-15 |
| 2020-09-30 | $54.74K 10-Q · filed 2021-11-15 |